Hamano K, Kinjo M, Kumazawa J
Department of Urology, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Eur Urol. 1992;22(2):153-7. doi: 10.1159/000474744.
Flow-cytometric (FCM) DNA analysis was performed in 534 samples from 140 bladder tumor cases and was compared with histopathological findings. Frequency of DNA aneuploidy was closely correlated with tumor grade. Namely the incidences of DNA aneuploidy were 20% in grade 0 (papilloma), 25.6% in grade 1, 57.7% in grade 2 and 95.7% in grade 3. Invasive tumors showed a significantly higher incidence of DNA aneuploidy than superficial papillary tumors. Frequency of DNA aneuploidy of CIS was between them. Nonpapillary tumors showed a significantly higher incidence of DNA aneuploidy than papillary tumors. Tumors with vessel invasion did show a similarly higher incidence than those without. Approximately 10% of histologically normal mucosa taken from the bladder tumor patients showed DNA aneuploidy. The present study could support possibilities that FCM findings were highly correlated with tumor malignant potentials and were also able to predict precancerous lesions on histologically normal mucosa.
对140例膀胱肿瘤患者的534份样本进行了流式细胞术(FCM)DNA分析,并与组织病理学结果进行了比较。DNA非整倍体的频率与肿瘤分级密切相关。具体而言,0级(乳头状瘤)的DNA非整倍体发生率为20%,1级为25.6%,2级为57.7%,3级为95.7%。浸润性肿瘤的DNA非整倍体发生率明显高于浅表乳头状肿瘤。原位癌的DNA非整倍体频率介于两者之间。非乳头状肿瘤的DNA非整倍体发生率明显高于乳头状肿瘤。有血管侵犯的肿瘤的发生率也同样高于无血管侵犯的肿瘤。从膀胱肿瘤患者身上获取的组织学正常黏膜中,约10%显示出DNA非整倍体。本研究支持以下可能性:FCM结果与肿瘤恶性潜能高度相关,并且还能够预测组织学正常黏膜上的癌前病变。